Emergency department (ED)–based initiation of buprenorphine has been shown to increase engagement in outpatient treatment and reduce the risk of subsequent opioid overdose; however, rates of buprenorphine treatment in the ED and follow-up care for opioid use disorder (OUD) remain low in the U.S. In response to high opioid overdose death rates, the Pennsylvania Department of Human Services (DHS) implemented the Opioid Hospital Quality Improvement Program (O-HQIP) in 2019. The O-HQIP is the first statewide financial incentive program designed to increase engagement in OUD treatment, including buprenorphine treatment, for Medicaid-enrolled patients who have ED encounters. This cohort cohort study of 17, 428 Medicaid-enrolled patients demonstrated that the O-HQIP was associated with an increased initiation of buprenorphine in patients with OUD presenting to the ED. These findings suggest that statewide incentive programs may effectively improve outcomes for patients with OUD.
Published March 24, 2023
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Analysing India’s Unique Subnational WHO FCTC Article 5.3 Policies and Their Implementation Across 17…
Strengthening the Tobacco Cessation Ecosystem
Activity Report 2025 – Brazil
More Data Better Health – Brazilian People’s Perceptions of Risk Factors for Cancer
Relatório de Atividades 2025 – Brasil
Mais Dados Mais Saúde – Percepções da população brasileira sobre fatores de risco…
What Primary Care Records Reveal About Cancer Signs and Symptoms
O que os prontuários da atenção primária revelam sobre sinais e sintomas de…
CRVS Performance Measurement and Monitoring Resource Kit
Model Kentucky Ordinance Establishing a County Opioid Abatement Advisory Council